STXS : Summary for STEREOTAXIS INC COM USD0.001 - Yahoo Finance

U.S. Markets close in 4 hrs 13 mins

Stereotaxis, Inc. (STXS)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.54-0.01 (-1.82%)
As of 11:09 AM EST. Market open.
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close0.55
Bid0.93 x 1300
Ask0.95 x 1000
Day's Range0.52 - 0.57
52 Week Range0.47 - 1.95
Avg. Volume76,542
Market Cap11.83M
PE Ratio (TTM)-0.63
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Stereotaxis, Inc. :STXS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 9, 2016
    Capital Cube26 days ago

    Stereotaxis, Inc. :STXS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 9, 2016

    Categories: Yahoo Finance Get free summary analysis Stereotaxis, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Stereotaxis, Inc. – St. Jude Medical, Inc., Dextera Surgical, Inc., Boston Scientific Corporation, Spectranetics Corporation, Edwards Lifesciences Corporation, AtriCure, Inc., Integer Holdings Corporation and Johnson & Johnson (STJ-US, DXTR-US, ... Read more (Read more...)

  • GlobeNewswire28 days ago

    Stereotaxis Reports 2016 Third Quarter Financial Results

    Completed $24 million private placement equity financing Retired all outstanding debt at significant discount Appointed three board members with extensive medical device experience Shipped fifth Niobe ...

  • GlobeNewswirelast month

    Stereotaxis to Report Third Quarter 2016 Financial Results on November 7, 2016

    LOUIS, Nov. 02, 2016-- Stereotaxis, Inc., a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will release financial results for its 2016 ...